From Surf Wiki (app.surf) — the open knowledge base
Dilazep
Chemical compound
Chemical compound
| Drugs.com = | elimination_half-life =
Dilazep is a vasodilator that acts as an adenosine reuptake inhibitor.{{cite journal | vauthors = Deguchi H, Takeya H, Wada H, Gabazza EC, Hayashi N, Urano H, Suzuki K | title = Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes | journal = Blood | volume = 90 | issue = 6 | pages = 2345–56 | date = September 1997 | pmid = 9310485 | doi = 10.1182/blood.V90.6.2345 | doi-access = free }}
It is used for the treatment of cardiopathy and renal disorders.
Synthesis
The reaction of bis(3-hydroxypropyl)ethylene diamine (1) with 1-bromo-3-chloropropane (2) gives the homopiperazine derivative 3. Esterification by reaction with 3,4,5-trimethoxybenzoyl chloride (4) completes the synthesis of dilazep (5).
References
References
- PubChem. "Dilazep".
- "Pharmaceuticals". Kowa Company Ltd..
- [https://pharmaceutical-substances.thieme.com/ps/search-results?docUri=KD-04-0094 Thieme]
- GB1107470 idem Herbert Arnold, Kurt Pahls, Rolf Rebling,Norbert Brock, Hans-Dieter Lenke, {{US patent. 3532685 (1970 to Asta Werke Ag Chem Fab)
- (1964). "Über pharmakodynamisch wirksame 3,4,5-Trimethoxybenzoate und verwandte Ester von symmetrischen Bis-hydroxyalkylpiperazinen und-dialkylpolymethylendiaminen". Monatshefte für Chemie.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Dilazep — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report